TP53 and ependymoma: By comparison, both the carrier frequency and the genes involved were similar to the findings of Zhang et al. from their pediatric pan-cancer germline study (n = 1120) which included 67 ependymoma patients (4/67 (6%), NF1, NF2, TP53) [10].